The spectrum of cognitive impairment in Lewy body diseases
(2014) In Movement Disorders 29(5). p.21-608- Abstract
Cognitive impairment represents an important and often defining component of the clinical syndromes of Lewy body disorders: Parkinson's disease and dementia with Lewy bodies. The spectrum of cognitive deficits in these Lewy body diseases encompasses a broad range of clinical features, severity of impairment, and timing of presentation. It is now recognized that cognitive dysfunction occurs not only in more advanced Parkinson's disease but also in early, untreated patients and even in those patients with pre-motor syndromes, such as rapid eye movement behavior disorder and hyposmia. In recent years, the concept of mild cognitive impairment as a transitional or pre-dementia state in Parkinson's disease has emerged. This has led to much... (More)
Cognitive impairment represents an important and often defining component of the clinical syndromes of Lewy body disorders: Parkinson's disease and dementia with Lewy bodies. The spectrum of cognitive deficits in these Lewy body diseases encompasses a broad range of clinical features, severity of impairment, and timing of presentation. It is now recognized that cognitive dysfunction occurs not only in more advanced Parkinson's disease but also in early, untreated patients and even in those patients with pre-motor syndromes, such as rapid eye movement behavior disorder and hyposmia. In recent years, the concept of mild cognitive impairment as a transitional or pre-dementia state in Parkinson's disease has emerged. This has led to much research regarding the diagnosis, prognosis, and underlying neurobiology of mild cognitive impairment in Parkinson's disease, but has also raised questions regarding the usefulness of this concept and its application in clinical and research settings. In addition, the conundrum of whether Parkinson's disease dementia and dementia with Lewy bodies represent the same or different entities remains unresolved. Although these disorders overlap in many aspects of their presentations and pathophysiology, they differ in other elements, such as timing of cognitive, behavioral, and motor symptoms; medication responses; and neuropathological contributions. This article examines the spectrum and evolution of cognitive impairment in Lewy body disorders and debates these controversial issues in the field using point-counterpoint approaches.
(Less)
- author
- Goldman, Jennifer G ; Williams-Gray, Caroline ; Barker, Roger A LU ; Duda, John E and Galvin, James E
- organization
- publishing date
- 2014-04-15
- type
- Contribution to journal
- publication status
- published
- keywords
- Animals, Cognition, Cognition Disorders, Dementia, Humans, Lewy Body Disease, Risk Factors, Journal Article, Review
- in
- Movement Disorders
- volume
- 29
- issue
- 5
- pages
- 14 pages
- publisher
- John Wiley & Sons Inc.
- external identifiers
-
- scopus:84898785684
- pmid:24757110
- ISSN
- 0885-3185
- DOI
- 10.1002/mds.25866
- language
- English
- LU publication?
- no
- id
- be084c90-6fdd-40ad-bc26-5510dba2d515
- date added to LUP
- 2016-11-24 15:10:18
- date last changed
- 2024-06-01 20:29:43
@article{be084c90-6fdd-40ad-bc26-5510dba2d515,
abstract = {{<p>Cognitive impairment represents an important and often defining component of the clinical syndromes of Lewy body disorders: Parkinson's disease and dementia with Lewy bodies. The spectrum of cognitive deficits in these Lewy body diseases encompasses a broad range of clinical features, severity of impairment, and timing of presentation. It is now recognized that cognitive dysfunction occurs not only in more advanced Parkinson's disease but also in early, untreated patients and even in those patients with pre-motor syndromes, such as rapid eye movement behavior disorder and hyposmia. In recent years, the concept of mild cognitive impairment as a transitional or pre-dementia state in Parkinson's disease has emerged. This has led to much research regarding the diagnosis, prognosis, and underlying neurobiology of mild cognitive impairment in Parkinson's disease, but has also raised questions regarding the usefulness of this concept and its application in clinical and research settings. In addition, the conundrum of whether Parkinson's disease dementia and dementia with Lewy bodies represent the same or different entities remains unresolved. Although these disorders overlap in many aspects of their presentations and pathophysiology, they differ in other elements, such as timing of cognitive, behavioral, and motor symptoms; medication responses; and neuropathological contributions. This article examines the spectrum and evolution of cognitive impairment in Lewy body disorders and debates these controversial issues in the field using point-counterpoint approaches.</p>}},
author = {{Goldman, Jennifer G and Williams-Gray, Caroline and Barker, Roger A and Duda, John E and Galvin, James E}},
issn = {{0885-3185}},
keywords = {{Animals; Cognition; Cognition Disorders; Dementia; Humans; Lewy Body Disease; Risk Factors; Journal Article; Review}},
language = {{eng}},
month = {{04}},
number = {{5}},
pages = {{21--608}},
publisher = {{John Wiley & Sons Inc.}},
series = {{Movement Disorders}},
title = {{The spectrum of cognitive impairment in Lewy body diseases}},
url = {{http://dx.doi.org/10.1002/mds.25866}},
doi = {{10.1002/mds.25866}},
volume = {{29}},
year = {{2014}},
}